Search Results - "Mather, S. J."

Molecular Imaging of Inflammation/Infection: Nuclear Medicine and Optical Imaging Agents and Methods by Signore, A, Mather, S. J, Piaggio, G, Malviya, G, Dierckx, R. A

“…Signore et al discuss inflammation, radiopharmaceuticals and nuclear medicine imaging…”
Get full text

Bifunctional bisphosphonate complexes for the diagnosis and therapy of bone metastases by Torres Martin de Rosales, R, Finucane, C, Mather, S J, Blower, P J

“…Easily synthesised and structurally well-defined novel imaging/therapeutic radiopharmaceutical agents for bone metastases are described…”
Get more information

General aspects of the cellular response to low- and high-LET radiation by Pouget, J P, Mather, S J

“…Radiobiological studies have shown for some time that the effects of ionising radiation on cells are mainly explained by modification of the DNA. Numerous…”
Get full text

Tositumomab and Iodine I 131 Tositumomab for Recurrent Indolent and Transformed B-Cell Non-Hodgkin’s Lymphoma by DAVIES, A. J, ROHATINER, A. Z. S, MATHER, S. J, CLAYTON, J, FOLEY, R, JAN, H, KROLL, S, HARRIS, M, AMESS, J, NORTON, A. J, LISTER, T. A, RADFORD, J. A, HOWELL, S, BRITTON, K. E, OWENS, S. E, MICALLEF, I. N, DEAKIN, D. P, CARRINGTON, B. M, LAWRANCE, J. A, VINNICOMBE, S

“…An open-label phase II study was conducted at two centers to establish the efficacy and safety of tositumomab and iodine I 131 tositumomab at first or second…”
Get full text

99m-Technetium-labelled peptide-HYNIC conjugates: effects of lipophilicity and stability on biodistribution by Decristoforo, Clemens, Mather, Stephen J

“…The aim of this study was to explore the effects of lipophilicity and stability on the biodistribution of 99mTc labelled peptides through the use of different…”
Get full text

Resistance to the tyrosine kinase inhibitor axitinib is associated with increased glucose metabolism in pancreatic adenocarcinoma by Hudson, C D, Hagemann, T, Mather, S J, Avril, N

“…Alterations in energy (glucose) metabolism are key events in the development and progression of cancer. In pancreatic adenocarcinoma (PDAC) cells, we…”
Get full text

Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence by Decristoforo, C, Mather, S J

“…In this paper the preclinical evaluation of the somatostatin analogue RC160 labelled with technetium-99m using bifunctional chelators (BFCs) based on the…”
Get full text

PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In by Roosenburg, S, Laverman, P, Joosten, L, Cooper, M S, Kolenc-Peitl, P K, Foster, J M, Hudson, C, Leyton, J, Burnet, J, Oyen, W J G, Blower, P J, Mather, S J, Boerman, O C, Sosabowski, J K

“…Cholecystokinin-2 (CCK-2) receptors, overexpressed in cancer types such as small cell lung cancers (SCLC) and medullary thyroid carcinomas (MTC), may serve as…”
Get full text

Fasting regimens for regional ophthalmic anaesthesia a survey of members of the British Ophthalmic Anaesthesia Society by STEEDS, C, MATHER, S. J

“…Members of the British Ophthalmic Anaesthesia Society were surveyed using a postal questionnaire. The response rate was 72.3%. Respondents were asked about…”
Get full text

Reduction-Mediated Technetium-99m Labeling of Monoclonal Antibodies by Mather, Stephen J, Ellison, David

“…A simple and generally applicable method for labeling antibodies with technetium-99m (99mTc) is described. Following reduction of intrinsic disulphide bonds,…”
Get full text

Radiopharmaceuticals for the study of inflammatory processes: a review by Chianelli, M, Mather, S J, Martin-Comin, J, Signore, A

“…Recent advances in our understanding of the pathophysiology of inflammatory processes at the molecular level, combined with progress in radiopharmaceutical…”
Get more information

A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG) by Solanki, K K, Bomanji, J, Moyes, J, Mather, S J, Trainer, P J, Britton, K E

“…Radiolabelled meta-iodobenzylguanidine (MIBG) is widely used in the diagnosis, follow-up and treatment of patients with tumours of neural crest origin. Some…”
Get more information

Comparison of the Stability of Technetium-Labeled Peptides to Challenge with Cysteine by Stalteri, M. A, Bansal, S, Hider, R, Mather, S. J

“…We have labeled a series of short peptides with technetium-99m either by direct labeling at pH 11 or by exchange from [99mTc]technetium glucoheptonate. Typical…”
Get full text

Disturbed gastric emptying in the short bowel syndrome. Evidence for a 'colonic brake' by Nightingale, J M, Kamm, M A, van der Sijp, J R, Morris, G P, Walker, E R, Mather, S J, Britton, K E, Lennard-Jones, J E

“…Gastric emptying of liquid (orange juice containing technetium-99m (99mTc) labelled antimony sulphide colloid) and solid (570 kcal pancake containing 0.5 mm…”
Get full text

Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers by van der Sijp, J R, Kamm, M A, Nightingale, J M, Britton, K E, Mather, S J, Morris, G P, Akkermans, L M, Lennard-Jones, J E

“…Radio-opaque markers have a well established role in distinguishing between patients with normal and those with slow intestinal transit, but in the latter…”
Get full text

Molecular imaging and targeted therapy: on creativity, research and visionary spirits by Lucignani, G, Mather, S J

Get full text

Hybridization and cell uptake studies with radiolabelled antisense oligonucleotides by STALTERI, M.A, MATHER, S.J

“…Background Radiolabelled antisense oligonucleotides have been proposed as radiopharmaceuticals for imaging changes in the level of gene expression in vivo…”
Get full text

Radioimmunotherapy. Progress, potential and problems by Mather, S J, Britton, K E

Get full text

Innovation in radiopharmacy: progress and constraints? by Mather, S J

Get full text

Optimization of the small-scale synthesis of DOTA-Tyr3-octreotide by EDREIRA, M, MELENDEZ-ALAFORT, L, MATHER, S J

“…The clinical potential of In and Y labelled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugated Tyr-octreotide (DOTA-TOC) have been reported in…”
Get full text